To Train More Nurses, We Need More Nurse Educators

The Train More Nurses Act would help address these challenges by directing the U.S. Department of Health and Human Services (HHS), as well as the U.S. Labor Department, to conduct a review of nursing grant programs to identify opportunities to increase faculty at nursing schools nationwide, especially in underserved communities. The post To Train More…

Read More

57 new drugs were approved in 2024

That is according to the FDA. Nature Reviews Drug Discovery summarizes the progress to date as follows. The FDA’s Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) approved 57 new therapeutic drugs (NTD) in 2024. This is slightly above the average of 53 NTDs per year for 2014–2024,…

Read More

Blood Centers Complement Hospitals to Drive Cell and Gene Therapy Access

Blood centers are neutral partners, as they do not compete with hospitals for patients. Instead, they complement hospitals by providing a focused array of high-quality, specialized, patient-centric services, allowing hospitals to maintain primary relationships with patients and their families. The post Blood Centers Complement Hospitals to Drive Cell and Gene Therapy Access appeared first on…

Read More

THCB Gang Episode 146, Tuesday November 26

Joining Matthew Holt (@boltyboy) on #THCBGang on Tuesday November 26 at 1PM PT 4PM ET are THCB regular writer and ponderer of odd juxtapositions Kim Bellard (@kimbbellard); medical historian Mike Magee (@drmikemagee); and a new guest from Marsh McLennan, Employee Benefits Consultant Ryan Koo (@RyanKoo). You can see the video below & if you’d rather listen…

Read More

My Totally Wrong, Expert Predictions for Health Care 2025

By MICHAEL MILLENSON January In a blistering commentary, the American Medical Association’s flagship journal, JAMA, condemns the corrosive effect on patient care of the profit-seeking practices of health insurers. Separately, the organization announces that it’s selling the 13 journals in its JAMA Network to a private equity firm for $375 million “in order to enhance…

Read More